Drug Testing Locations - Harrah, OK

Drug Testing in Harrah, OK

Harrah, Oklahoma Statistics

In Harrah, OK, located in Oklahoma County, the rate of opioid-related hospitalizations has increased by 15% over the past five years.

Methamphetamine usage among young adults in Harrah, Oklahoma County, is reported to be 12% higher than the state average.

According to recent data, Harrah, Oklahoma County, saw a 25% increase in drug-related arrests last year.

Harrah, located within Oklahoma County, has a drug overdose death rate of 20 per 100,000 residents, which is above the national average.

In Harrah, Oklahoma County, over 35% of admissions for substance abuse treatment are for alcohol and marijuana combined.

According to Oklahoma County health officials, Harrah has seen a rise in prescription drug abuse cases among residents over 50.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Harrah, OK & Drug Testing Policies

Employers in Harrah, OK, are actively implementing drug testing policies to maintain a safe and productive working environment. Many companies require pre-employment screening and random drug tests to deter substance abuse among their workforce. These policies are in alignment with the U.S. Department of Labor's recommendations.

Local businesses in Harrah often collaborate with state agencies to access resources and training for effectively managing substance abuse challenges. The Oklahoma Employment Security Commission provides guidelines and assistance for employers in conducting drug tests and addressing workplace drug issues.

Government Efforts with Drug Problems in Harrah, OK

The government of Harrah, OK, in collaboration with Oklahoma County, has initiated several programs to counter drug abuse. The Oklahoma Department of Mental Health and Substance Abuse Services has been pivotal in implementing education and prevention programs targeting various age groups in the city.

Additionally, federal support through grants from the Substance Abuse and Mental Health Services Administration has enabled local agencies to enhance treatment facilities and outreach programs. Harrah has also partnered with law enforcement departments to enhance community policing efforts aimed at reducing drug-related activities.

Local Drug Busts & News in Harrah, OK

Harrah, OK, has been the scene of several significant drug busts in recent years, highlighting ongoing efforts to curtail illegal drug activities. In a notable operation, the Oklahoma County Sheriff's Department seized substantial quantities of methamphetamine and arrested multiple individuals involved in its distribution.

Local news outlets frequently report on collaborative drug raids conducted by law enforcement agencies within Harrah and surrounding areas. These events reflect the persistent dedication of law enforcement to battle drug crime and the proactive measures taken to ensure community safety.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Harrah, OK. Trusted by employers nationwide for accurate results and exceptional service.

Oklahoma DOT/Non DOT Physicals

Oklahoma Vision Tests

Oklahoma Audiograms

Oklahoma Respirator Fit Tests

Oklahoma Lift Tests

Oklahoma Background Checks

Clinical Testing Services

TB Testing in OK

Diabetes Testing in OK

Infectious Disease Testing in OK

Sickle Cell Anemia Testing in OK

Women/Men's Health Testing in OK

Resources & Citations

Oklahoma Department of Mental Health and Substance Abuse Services

Oklahoma Helpline

Network of Care Oklahoma

PreventionWorkz

2-1-1 Oklahoma

Valor Oklahoma

Narconon New Life Retreat, Oklahoma

The Roadback, Inc.

Oklahoma Drug and Alcohol Professional Counselor Certification

Drug Testing Near Harrah, OK

Del City, OK

Arcadia, OK

Wellston, OK

Bethel Acres, OK

Meeker, OK

Midwest City, OK

Spencer, OK

Luther, OK

Dale, OK

Nicoma Park, OK

McLoud, OK

Frequently Asked Questions

Customer Reviews